Research Article Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/cardiology.3.027

Late ECG Changes after Cisplatin-Based Chemotherapy in Testicular Cancer Survivors

  • 1International Laser Center CVTI, Bratislava, Slovak Republic
  • 2Institute of Pathological Physiology, Medical School of Comenius University, Bratislava, Slovak Republic
  • 3Medical University, Mainz, Germany
  • 4Department of Oncohematology, Faculty of Medicine, Comenius University and National Institute of Oncology, Bratislava, Slovak Republic
  • 52nd Department of Oncology, Faculty of Medicine, Comenius University and National Institute of Oncology, Bratislava, Slovak Republic
  • 6Slovak Medical University, Bratislava, Slovak Republic
+ Affiliations - Affiliations

Corresponding Author

Ljuba Bacharova, bacharova@ilc.sk

Received Date: September 30, 2021

Accepted Date: December 16, 2021


Background: Cisplatin-based therapy (CBT) represents currently a standard regimen for the testicular cancer treatment leading to longer survival of patients; as a consequence, the late cardiotoxicity can be manifested. In this study we analyzed the effect of CBT on the standard 12-lead ECG parameters in testicular cancer survivors.

Material and Methods: The electrocardiograms (ECG) of 173 patients with the germ cell tumor with a median follow-up duration of 9 years (ranged 5 to 32 years) were retrospectively analyzed. The patients were divided into four groups: Group CT: Orchidectomy plus CBT (n=133); Group AS: Orchidectomy only (n=18); Group RT: Orchidectomy plus adjuvant radiotherapy (n=14); Group CTRT: Orchidectomy plus adjuvant radiotherapy in combination with CBT (n=8). Heart rate (HR), QT and QTc intervals, the maximum spatial QRS vector amplitude, the electrical axis, the QRS complex amplitudes in individual leads and the maximum spatial T vector amplitude were analyzed.

Results: The HR and QT/QTc intervals were within normal limits. The most frequent ECG finding was the left anterior fascicular block, with the highest occurrence in the group CTRT (75%). The amplitudes of aVL, V6 and Tmax differed significantly between the AS group and the CT and RT/CTRT groups. The General Linear Model did not show a significant effect of therapy, but a significant effect of age and the waist circumference, respectively.

Conclusion: Cisplatin-based therapy did not result in pathological ECG changes. The slight ECG changes were associated with age and obesity, but not the therapy.


Testicular cancer, Cisplatin-based therapy, Survivors, ECG

Author Information X